SpringerLink
Log in

ASO Author Reflections: Prognostic Value of Subgrading G2 Pancreatic Neuroendocrine Tumors as 2A versus 2B

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Data availability

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

  1. Corti F, Brizzi MP, Amoroso V, Giuffrida D, Panzuto F, Campana D, Prinzi N, Milione M, Cascella T, Spreafico C, Randon G, Oldani S, Leporati R, Scotto G, Pulice I, Stocchetti BL, Porcu L, Coppa J, Di Bartolomeo M, de Braud F, Pusceddu S. Assessing the safety and activity of cabozantinib combined with lanreotide in gastroenteropancreatic and thoracic neuroendocrine tumors: rationale and protocol of the phase II LOLA trial. BMC Cancer. 2023;23(1):908. https://doi.org/10.1186/s12885-023-11287-2.PMID:37752423;PMCID:PMC10523723.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Müller C, Kreissl MC, Klose S, Krause A, Keitel V, Venerito M. Long-term treatment with streptozocin/5-fluorouracil chemotherapy in patients with metastatic pancreatic neuroendocrine tumors: Case series. Medicine Balt. 2022;101(4):e28610. https://doi.org/10.1097/MD.0000000000028610.PMID:35089197;PMCID:PMC8797514.

    Article  Google Scholar 

  3. Eren OC, Bagci P, Balci S, et al. Subgrading of G2 pancreatic neuroendocrine tumors as 2A (Ki67 3% to < 10%) versus 2B (10% to ≤ 20%) identifies behaviorally distinct subsets in kee** with the evolving management protocols. Ann Surg Oncol. 2024. https://doi.org/10.1245/s10434-024-15632-y.

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

This initial and validation cohorts of this study were presented as abstracts in USCAP 2022 and USCAP 2024 annual meetings.

Funding

The authors received no specific funding for this work.

Author information

Authors and Affiliations

  1. Department of Pathology, Koç University, Koç University Hospital, Istanbul, Türkiye

    Ozgur Can Eren MD, Burcu Saka MD, Orhun Cig Taskin MD, Yersu Kapran MD & N. Volkan Adsay MD

  2. Department of Pathology, Marmara University, Istanbul, Türkiye

    Pelin Bagci MD

  3. Department of Pathology, Memorial Sisli Hospital, Istanbul, Türkiye

    Serdar Balci MD

  4. Department of Pathology, St. Marianna University, Kawasaki, Kanagawa, Japan

    Nobuyuki Ohike MD

  5. Department of Pathology, Hacettepe University, Ankara, Türkiye

    Cenk Sokmensuer MD & Can Berk Leblebici MD

  6. Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA

    Yue Xue MD, PhD

  7. Department of Pathology, Emory University, Atlanta, GA, USA

    Michelle D. Reid MD, MSc & Alyssa M. Krasinskas MD

  8. Department of Surgery, Emory University, Atlanta, GA, USA

    David Kooby MD, Shishir K. Maithel MD & Juan Sarmiento MD

  9. Department of Pathology, Piedmont Hospital, Atlanta, GA, USA

    Jeanette D. Cheng MD

  10. Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA

    Zeynep Tarcan MD & Olca Basturk MD

  11. Department of Diagnostics and Public Health, Section of Pathology and ARC-Net Research Centre, University of Verona, Verona, Italy

    Claudio Luchini MD, PhD & Aldo Scarpa MD

Authors
  1. Ozgur Can Eren MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pelin Bagci MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Serdar Balci MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nobuyuki Ohike MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Burcu Saka MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Cenk Sokmensuer MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Can Berk Leblebici MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yue Xue MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Michelle D. Reid MD, MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Alyssa M. Krasinskas MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. David Kooby MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Shishir K. Maithel MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Juan Sarmiento MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Jeanette D. Cheng MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Orhun Cig Taskin MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Yersu Kapran MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Zeynep Tarcan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Claudio Luchini MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. Aldo Scarpa MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  20. Olca Basturk MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  21. N. Volkan Adsay MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to N. Volkan Adsay MD.

Ethics declarations

Disclosures

The authors declare that they have no conflict of interest to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article refers to: Eren OC, Bagci P, Balci S, et al. Subgrading of G2 pancreatic neuroendocrine tumors as 2A (Ki67 3% to < 10%) versus 2B (10% to ≤ 20%) identifies behaviorally distinct subsets in kee** with the evolving management protocols. Ann Surg Oncol. (2024). https://doi.org/10.1245/s10434-024-15632-y.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Eren, O.C., Bagci, P., Balci, S. et al. ASO Author Reflections: Prognostic Value of Subgrading G2 Pancreatic Neuroendocrine Tumors as 2A versus 2B. Ann Surg Oncol (2024). https://doi.org/10.1245/s10434-024-15728-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1245/s10434-024-15728-5

Search

Navigation